Servicio de Nefrología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Mexico.
Centro Universitario de Ciencias de la Salud CUCS, Universidad de Guadalajara, Guadalajara, Mexico.
BMC Nephrol. 2018 Nov 14;19(1):324. doi: 10.1186/s12882-018-1121-0.
Acyclovir is one of the most common prescribed antiviral drugs. Acyclovir nephrotoxicity occurs in approximately 12-48% of cases. It can present in clinical practice as acute kidney injury (AKI), crystal-induced nephropathy, acute tubulointerstitial nephritis, and rarely, as tubular dysfunction. Electrolytes abnormalities like hypokalemia, were previously described only when given intravenously.
A 54 year-old female presented with weakness and lower extremities paresis, nausea and vomiting after receiving oral acyclovir. Physical examination disclosed a decrease in the patellar osteotendinous reflexes (++ / ++++). Laboratory data showed a serum creatinine level of 2.1 mg/dL; serum potassium 2.1 mmol/L. Kidney biopsy was obtained; histological findings were consistent with acute tubular necrosis and acute tubulointerstitial nephritis. The patient was advised to stop the medications and to start with oral and intravenous potassium supplement, symptoms improved and continued until serum potassium levels were > 3.5 meq/L.
The case reported in this vignette is unique since it is the first one to describe hypokalemia associated to acute tubular necrosis induced by oral acyclovir.
阿昔洛韦是最常用的处方抗病毒药物之一。阿昔洛韦肾毒性在大约 12-48%的病例中发生。它在临床实践中可表现为急性肾损伤 (AKI)、晶体诱导的肾病、急性肾小管间质性肾炎,很少表现为肾小管功能障碍。电解质异常如低钾血症,以前仅在静脉给药时描述过。
一名 54 岁女性在口服阿昔洛韦后出现乏力和下肢瘫痪、恶心和呕吐。体格检查发现髌腱反射减退(++/++++)。实验室数据显示血清肌酐水平为 2.1mg/dL;血清钾 2.1mmol/L。进行了肾脏活检;组织学发现与急性肾小管坏死和急性肾小管间质性肾炎一致。建议患者停止用药,并开始口服和静脉补钾,症状改善并持续到血清钾水平>3.5meq/L。
本病例报告是独特的,因为它是第一个描述由口服阿昔洛韦引起的急性肾小管坏死相关低钾血症的病例。